MLL Münchner Leukämielabor
Our aim is to offer the best leukemia diagnostics and to make it available to all patients. See behind. Go beyond.
Our aim is to offer the best leukemia diagnostics and to make it available to all patients. See behind. Go beyond.
Münchner Leukämie Labor GmbH (MLL) is a biotechnology startup specializing in leukemia research and treatment, operating within the health care industry. Founded in 2005, MLL has demonstrated a strong commitment to advancing the field of biotechnology with a specific focus on leukemia. Despite the lack of specific information regarding its headquarters, last investment, or last investment investors, MLL's dedication to addressing critical health issues, such as leukemia, presents a compelling opportunity for investment within the biotechnology and healthcare sectors.
There is no investment information
No recent news or press coverage available for MLL Münchner Leukämielabor.
We care about your data, and we'd love to use cookies make your experience better.
